100000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Organization and Operations
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Inventory
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Prepaid and Other Current Assets
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Long-term Debt
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - License and Collaboration Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Net Loss per Common Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Inventory (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Prepaid and Other Current Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Long-term Debt (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Net Loss per Common Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Nature of Organization and Operations - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales - Schedule of Disaggregation of Product Revenue by Major Source (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales - Summary of Product Revenue Allowance and Reserve Categories (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales - Schedule of Customer Accounted for 10% of More of Gross Product Revenues and Accounts Receivable (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Product Revenues, Accounts Receivable, and Reserves for Product Sales - Schedule of Factoring of Accounts Receivable and Associated Fees (Details
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Inventory - Schedule of Inventory Current (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Inventory - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Prepaid and Other Current Assets - Summary of Prepaid and Other Current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Prepaid and Other Current Assets - Summary of Prepaid and Other Current Assets (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Prepaid and Other Current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Long-term Debt - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Long-term Debt - Schedule of Outstanding Balance of Convertible Notes (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Long-term Debt - Schedule of Interest Expense Recognized Related to Convertible Notes (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Long-term Debt - Financing Agreement and Credit Facility - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Long-term Debt - Summary of Credit Facility (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Long Term Debt - Summary of Interest Expense Recognized Related to Credit Facility (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments and the Related Fair Value Hierarchy of the Valuation Techniques Utilized (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Fair Value Measurements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Income Taxes - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - License and Collaboration Agreements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Commitments and Contingencies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Net Loss per Common Share - Summary of Basic and Diluted Net Loss per Common Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Net Loss per Common Share - Summary of Shares Outstanding that were Excluded from Calculation of Diluted Net Loss Per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Segment Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Segment Information - Schedule of Segment Revenue, Segment Profit or Loss and Significant Segment Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Product sales reserves
Product Sales Reserves
Product sales reserves.
Statement [Line Items]
Statement [Line Items]
Debt Instrument
Debt Instrument [Axis]
Accounts receivable
Increase (Decrease) in Accounts Receivable
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Convertible Senior Notes Due 2026 [Member]
Convertible Senior Notes Due Two Thousand Twenty Six [Member]
Convertible senior notes due two thousand twenty six.
Development milestone achievement
Development Milestone Achievement
Development milestone achievement.
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
External General and Administrative Costs
External general and administrative costs.
External general and administrative costs
Revenue:
Revenues [Abstract]
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activities
Accrued research and development current.
Accrued Research And Development Current
Accrued research and development
Debt Instrument, Covenant Description
Debt instrument, covenant description
Number of Operating Segments
Number of operating segment
Beginning balance, Shares
Ending balance, Shares
Shares, Outstanding
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
Empaveli And Aspaveli [Member]
EMPAVELI and Aspaveli member
EMPAVELI and Aspaveli [Member]
Long-term Debt, Type
Long-Term Debt, Type [Domain]
Other segment items
Segment Reporting, Other Segment Item, Amount
Customer D [Member]
Customer D [Member]
Customer D.
Aggregate milestone payments upon achievement of specified one time regulatory development and commercial milestone events.
Aggregate Milestone Payments Upon Achievement of Specified One Time Regulatory Development and Commercial Milestone Events
Aggregate milestone payments upon achievement of specified one time regulatory development and commercial milestone events
Available Additional Draw Amount Upon Satisfaction of Cash Requirements
Available additional draw amount upon satisfaction of cash requirements.
Available additional draw amount upon satisfaction of cash requirements
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Total inventory
Inventory
Inventory.
Product and Service
Product and Service [Axis]
Lender Name [Axis]
Convertible notes
Convertible Senior Notes Noncurrent
Convertible senior notes.
Base Rate [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Tim Sullivan [Member]
Timothy Sullivan [Member]
Timothy Sullivan.
Shares expected to be purchased under employee stock purchase plan
Employee Stock [Member]
External research and development costs
External Research and Development Costs
External research and development costs.
Concentration Risk Benchmark [Axis]
Interest Expense, Nonoperating
Interest expense
Interest expense
Product Revenues Accounts Receivable And Reserves For Product Sales [Line Items]
Product Revenues Accounts Receivable And Reserves For Product Sales [Line Items]
Product revenues, accounts receivable, and reserves for product sales.
Sale of Stock
Sale of Stock [Domain]
Total future minimum payments
Principal
Long-Term Debt, Gross
Credit Facility [Member]
Credit facility.
Collaborative arrangement, number of research programs.
Collaborative Arrangement Number Of Research Programs
Number of research programs
Milestone payments based on annual sales milestones
Sales Milestone Payments Based On Achievement Of Annual Sales Milestones
Sales milestone payments based on achievement of annual sales milestones.
Entity Central Index Key
Entity Central Index Key
Credits and payments made
Product Revenue Allowances And Reserves, Credit And Payments Made
Product revenue allowances and reserves, credit and payments made.
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Refund filed under CARES Act relating to employee retention credit
Refund Filed under CARES Act Relating to Employee Retention Credit
Refund filed under CARES Act relating to employee retention credit.
Common Stock, Shares, Issued, Total
Common stock, issued
Common Stock, Shares, Issued
Net proceeds from the sale of the notes
Proceeds from Convertible Debt
David Watson [Member]
David Watson.
Income Statement [Abstract]
Maximum credit per employee for each calendar quarter
Maximum Credit per Employee for Each Calendar Quarter
Maximum credit per employee for each calendar quarter.
Investment Income, Nonoperating, Total
Interest income
Investment Income, Nonoperating
Interest income
Entity Address, State or Province
Entity Address, State or Province
Net loss before taxes
Net loss before taxes
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Threshold percentage of stock price trigger
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
Amortization of discounts for convertible notes.
Amortization Of Discounts For Convertible Notes
Amortization of discounts for convertible notes
Concentration Risk Type [Domain]
Internal Selling, General and Administrative Cost
Internal selling, general and administrative cost.
Internal selling, general and administrative costs
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contract with Customer, Liability, Revenue Recognized
Revenue recognized
Customer [Axis]
Senior Secured Credit Facility [Member]
Senior Secured Credit Facility [Member]
Customer Concentration Risk [Member]
Customer Concentration Risk [Member]
2020 Convertible Notes [Member]
Two Thousand Twenty Convertible Notes [Member]
2020 Convertible notes.
Royalties entitled to receive after first commercial sale of applicable licensed product period.
Royalties Entitled To Receive After First Commercial Sale Of Applicable Licensed Product Period
Royalties entitled to receive after first commercial sale of applicable licensed product period
Liability Class
Liability Class [Axis]
Collaboration and License Agreement [Member]
Collaboration And License Agreement [Member]
Collaboration and license agreement.
Raw materials
Inventory, Raw Materials, Gross
Inventory, Raw Materials, Gross, Total
Payments of transactions cost
Payments of Debt Issuance Costs
SFJ Agreement [Member]
S F J Agreement [Member]
SFJ agreement [member].
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Proceeds From Initial Draw Amount Under Credit Facility
Proceeds from initial draw amount under credit facility.
Proceeds from initial draw amount under credit facility
Cover [Abstract]
Collaborative arrangement, maximum extendable term of agreement.
Collaborative Arrangement Maximum Extendable Term Of Agreement
Collaboration agreement maximum extendable term
Earnings Per Share, Basic
Net loss per common share, basic
Net loss per common share, basic
Regulatory milestone payments
Regulatory Milestone Payments Based On Achievement
Regulatory milestone payments based on achievement.
Aspaveli [Member]
Aspaveli.
Aspaveli [Member]
Operating expenses:
Operating Expenses [Abstract]
Proceeds from Sale of Other Receivables
Accounts receivable sold
2019 Convertible Notes [Member]
Two Thousand Nineteen Convertible Notes [Member]
2019 Convertible notes.
Net carrying amount
Long-term debt
Long-Term Debt
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Fair Value, Nonrecurring [Member]
Fair Value, Nonrecurring [Member]
Segment Reporting [Abstract]
Current assets:
Assets, Current [Abstract]
Summary of Prepaid and Other Current Assets
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Net cash used in operating activities
Net Cash Provided by (Used in) Operating Activities
Royalty Expense
Royalty expense
Product and Service
Product and Service [Domain]
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Operating lease, term of contract
Lessee, Operating Lease, Term of Contract
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Total
Property and equipment, net
Property, Plant and Equipment, Net
Operating Activities
Net Cash Provided by (Used in) Operating Activities [Abstract]
Fair Value, Recurring [Member]
Fair Value, Recurring [Member]
Ending balance
Beginning Balance
Product Revenue Allowances and Reserves
Product revenue allowances and reserves.
Common stock, par value
Common Stock, Par or Stated Value Per Share
Accrued royalties
Accrued Royalties, Current
Stock options to purchase common stock
Unrealized gain on available-for-sale investments
Unrealized gain/(loss) on marketable securities
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Karen L Lewis [Member]
Karen L Lewis.
Sixth Street Financing Agreement [Member]
Sixth street financing agreement.
Statement of Cash Flows [Abstract]
Counterparty Name
Counterparty Name [Axis]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Nur Nicholson [Member]
Nur Nicholson.
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity Components
Equity Components [Axis]
Payment of convertible debt discounts and commissions
Payment Of Convertible Debt Discounts And Commissions
Payment of convertible debt discounts and commissions.
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Summary of Basic and Diluted Net Loss per Common Share
Summary of Shares Outstanding that were Excluded from Calculation of Diluted Net Loss Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Line of Credit Facility, Maximum Borrowing Capacity
Maximum borrowing capacity
Exchange Agreements [Member]
Exchange Agreements [Member]
Exchange agreements.
Liability Component [Member]
Liability Component [Member]
Liability component.
Amendment Flag
Amendment Flag
Trading price per principal amount
Debt Instrument Convertible Threshold Trading Price Per Principal Amount
Debt instrument convertible threshold trading price per principal amount.
Operating Lease, Liability, Noncurrent
Lease liabilities
Debt Instrument, Name
Debt Instrument, Name [Domain]
Minimum Cash Requirements to Draw Additional Loan Under Credit Facility
Minimum cash requirements to draw additional loan under credit facility.
Minimum cash requirements to draw additional loan under credit facility
Market Capitalization Threshold Percentage for Credit Facility
Market capitalization threshold percentage for credit facility.
Market capitalization threshold percentage for credit facility
Market Capitalization Threshold for Credit Facility
Market capitalization threshold for credit Facility.
Market capitalization threshold for credit facility
Product Revenue Allowance and Reserves [Member]
Product Revenue Allowance and Reserves [Member]
Product revenue allowance and reserves.
Net loss
Net loss
Long-term inventory
Inventory, Noncurrent
Inventory, Noncurrent, Total
Initial conversion price
Debt Instrument Convertible Initial Conversion Price
Debt Instrument, convertible, initial conversion price.
Issuance of common stock upon exercise of stock options, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Variable Rate [Domain]
Customer [Domain]
Schedule of Outstanding Balance of Convertible Notes
Schedule of Debt [Table Text Block]
Equity Component
Equity Component [Domain]
Statistical Measurement
Statistical Measurement [Domain]
Segment Reporting, Expense Information Used by CODM, Type [Extensible Enumeration]
Long-Term Line of Credit, Noncurrent
Long-term credit facility
Total interest expense
Debt interest expense
Interest Expense, Debt
Other Nonoperating Income (Expense), Total
Other Nonoperating Income (Expense)
Other (expense)/ income, net
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
2010 License Agreement [Member]
Two Thousand Ten License Agreement [Member]
Two thousand ten license agreement.
Proceeds from Lines of Credit
Proceeds from Lines of Credit, Total
Proceeds from credit facility
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Preferred Stock, Shares Issued, Total
Preferred stock, issued
Preferred Stock, Shares Issued
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
Convertible notes held in treasury
Convertible Notes Held in Treasury
Convertible notes held in treasury.
Patent License Agreement with Penn (Non-ophthalmic Fields of Use) [Member]
Patent License Agreement With Penn (Non-ophthalmic Fields of Use) [Member]
Patent License Agreement with Penn (Non-ophthalmic Fields of Use).
Payables and Accruals [Abstract]
Restricted cash
Restricted Cash, Current
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
License and Collaboration Agreements
Collaborative Arrangement Disclosure [Text Block]
Comprehensive loss, net of tax
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
2019 Convertible Notes And 2020 Convertible Notes [Member]
Two Thousand Nineteen Convertible Notes And Two Thousand Twenty Convertible Notes [Member]
Two thousand nineteen convertible notes and two thousand twenty convertible notes member.
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, outstanding
Common Stock, Shares, Outstanding
Product revenue reserves current.
Product revenue reserves current
Product revenue reserves
Purchase of available-for-sale securities
Payments to Acquire Debt Securities, Available-for-Sale
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Proceeds from maturity of available-for-sale securities
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale
Antidilutive Securities
Antidilutive Securities [Axis]
Provision related to sales in the current year
Product Revenue Allowances And Reserves, Provision Related To Sales In The Current Year
Product revenue allowances and reserves, provision related to sales in the current year.
Entity Interactive Data Current
Entity Interactive Data Current
Payment for Buyout of Development Liability which is Due in Twenty Twenty-five
Payment for Buyout of Development Liability which is Due in Twenty Twenty-five
Payment for buyout of development liability which is due in 2025
Product revenue, net [Member]
Product Revenue, Net [Member]
Product [Member]
Commitments And Contingencies [Line Items]
Commitments And Contingencies [Line Items]
Commitments and contingencies.
Maximum number of employees with employers eligible for refundable tax credit
Maximum Number of Employees with Employers Eligible for Refundable Tax Credit
Maximum number of employees with employers eligible for refundable tax credit.
Redemption price, percentage
Debt Instrument, Redemption Price, Percentage
Accounting Standards Update
Accounting Standards Update [Domain]
Document Quarterly Report
Document Quarterly Report
Total cash, cash equivalents, and restricted cash
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Balance Sheet Location
Statement of Financial Position Location, Balance [Axis]
Statistical Measurement
Statistical Measurement [Axis]
Debt instrument, due and payment description
Debt Instrument, Payment Terms
Total Financial Assets
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Related and Nonrelated Parties [Domain]
Schedule of Disaggregation of Product Revenue by Major Source
Disaggregation of Revenue [Table Text Block]
Regulatory milestone incurred
Regulatory milestone incurred based on achievement.
Regulatory Milestone Incurred Based On Achievement
Licensing and other revenue [Member]
Licensing And Other Revenue [Member]
Licensing and other revenue.
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies [Text Block]
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Threshold consecutive trading days
Debt Instrument, Convertible, Threshold Consecutive Trading Days
Prepaid assets
Increase (Decrease) in Prepaid Expense
Total assets
Assets
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
SYFOVRE [Member]
SYFOVRE [Member]
Syfovre.
Recently Issued Accounting Standards
New Accounting Pronouncements, Policy [Policy Text Block]
Entity Address, City or Town
Entity Address, City or Town
Total Accumulated Other Comprehensive Income (Loss) [Member]
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Loss [Member]
Segments [Axis]
Available Initial Draw Amount Under Credit Facility
Available initial draw amount under credit facility.
Available initial draw amount under credit facility
Principal amount
Debt Instrument, Face Amount
Deposits and other current assets
Deposits and Other Current Assets
Deposits and other current assets.
ASU 2020-06 [Member]
Accounting Standards Update 2020-06 [Member]
Depreciation, Total
Depreciation expense
Depreciation
Net Income (Loss) Attributable to Parent [Abstract]
Numerator:
Schedule of Segment Reporting Information, by Segment [Table]
Development cost reimbursement received.
Development Cost Reimbursement Received
Development cost reimbursement received
Terms of conversion
Debt Instrument, Convertible, Terms of Conversion Feature
Private Placement [Member]
Private Offering [Member]
Prepaid and Other Current Assets
Prepaid and Other Current Assets [Text Block]
Prepaid and other current assets.
Prepaid Expense and Other Assets, Current [Abstract]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Fair Value Disclosures [Abstract]
Issuance of common stock upon exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
Current liabilities:
Liabilities, Current [Abstract]
Product Sales Receivable [Member]
Accounts Receivable [Member]
EMPAVELI [Member]
EMPAVELI (Pegcetacoplan) [Member]
Empaveli (Pegcetacoplan).
Document Type
Document Type
Accounting Standards Update
Accounting Standards Update [Axis]
Security 12b Title
Title of 12(b) Security
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Balance Sheet Location
Statement of Financial Position Location, Balance [Domain]
Statement of Stockholders' Equity [Abstract]
Document Fiscal Period Focus
Document Fiscal Period Focus
Research and Development Expense, Total
Research and development
Research and Development Expense
Payments of employee tax withholding related to equity-based compensation
Payment, Tax Withholding, Share-Based Payment Arrangement
Increase Decrease In Right-Of-Use Assets And Lease Liabilities
Increase (decrease) in right-of-use assets and lease liabilities.
Right-of-use assets and lease liabilities
Asset Class
Asset Class [Domain]
Upfront payment
Upfront Payment
Upfront payment.
Initial cap price
Debt Instrument Convertible Initial Conversion Cap Price
Debt Instrument, convertible, initial conversion cap price.
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
A Sinclair Dunlop [Member]
A Sinclair Dunlop.
Internal Research and Development Costs
Internal research and development costs.
Internal research and development costs
Non-current assets:
Assets, Noncurrent [Abstract]
Sale of Stock
Sale of Stock [Axis]
Investing Activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Marketable Securities, Current, Total
Marketable securities
Marketable Securities, Current
Total Product revenue, net
Revenue from Contract with Customer, Excluding Assessed Tax
Revenue
Total revenue
Income Tax Disclosure [Text Block]
Income Taxes
Receivable from collaboration agreement
Receivable from Collaboration Agreement Current
Receivable from collaboration agreement current.
Number of counterparties
Debt Instrument Number Of Counterparties
Debt instrument number of counterparties.
Schedule of Interest Expense Recognized Related to Convertible Notes
Schedule Of Interest Expense Related To Debt Instruments [Table Text Block]
Schedule of interest expense related to debt instruments.
Vehicles [Member]
Vehicles [Member]
Selling, General and Administrative Expense, Total
Selling, General and Administrative Expense
Selling, general and administrative
Credit Facility [Domain]
license agreement
Collaborative License Agreement Payable
Collaborative license agreement payable.
Debt instrument, frequency of periodic payment
Debt Instrument, Frequency of Periodic Payment
Other
Other Accrued Liabilities, Current
Increase (Decrease) in Accounts Payable, Total
Accounts payable
Increase (Decrease) in Accounts Payable
Liabilities and Stockholders' Equity
Liabilities and Equity [Abstract]
Schedule of Customer Accounted for 10% of More of Gross Product Revenues and Accounts Receivable
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Document Period End Date
Document Period End Date
Net cash provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Employee Benefits and Share-Based Compensation
Share-based compensation expense
Incurred any cost to defend lawsuits or settle claims
Litigation Settlement, Amount Awarded to Other Party
Liabilities, Noncurrent [Abstract]
Long-term liabilities:
Threshold trading days
Debt Instrument, Convertible, Threshold Trading Days
Antidilutive securities excluded from computation of earnings per share, amount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Share-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Aggregate principal amount converted
Convertible Notes exchanged for common stock
Debt Conversion, Converted Instrument, Amount
Total accrued expenses
Accrued expenses
Accrued Liabilities, Current
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Income tax expense
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Income tax expense
Percentage of qualified wages paid to employees under employee retention credit
Percentage of Qualified Wages Paid to Employees under Employee Retention Credit
Percentage of qualified wages paid to employees under employee retention credit.
Trading Symbol
Trading Symbol
University of Pennsylvania [Member]
University Of Pennsylvania [Member]
University of pennsylvania.
Variable Rate [Axis]
Impact of adoption of ASU 2020-06
Total stockholders' equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Customer A.
Customer A [Member]
Customer A [Member]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Axis]
Other liabilities
Other Liabilities, Noncurrent
Other Liabilities, Noncurrent, Total
Conversion price
Debt Instrument, Convertible, Conversion Price
Collaborative Arrangement Upfront Milestone Amount Payable
Collaborative arrangement upfront milestone amount payable.
Upfront milestone payable
Restricted Stock Units (RSUs) [Member]
Unvested restricted stock units
Deferred revenue
Increase (Decrease) in Deferred Revenue
Minimum Required Convertible Unsecured Notes for Additional Loan Amount
Minimum required convertible unsecured notes for additional loan amount.
Minimum required convertible unsecured notes for additional loan amount
Change in accounting principle accounting standards update adopted
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Customer C [Member]
Customer C [Member]
Customer C.
Nature of Organization and Operations
Nature of Operations [Text Block]
Reported Segment [Member]
Reportable Segment, Aggregation before Other Operating Segment [Member]
Bachem [Member]
Bachem Member
Bachem member.
Interest Expense, Debt [Abstract]
Capped Call Transactions [Member]
Capped Call Transaction [Member]
Capped call transaction.
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Concentration risk
Concentration Risk, Percentage
James Chopas [Member]
James Chopas.
Other Commitment
Other Commitment
Other Commitment, Total
Other non-cancellable purchase commitments
Scenario
Scenario [Axis]
Collaborative Arrangement Third Party License Expenses
Collaborative arrangement third party license expenses.
Third party license expenses
Security Exchange Name
Security Exchange Name
Counterparty Name
Counterparty Name [Domain]
Fair Value by Liability Class
Fair Value by Liability Class [Domain]
Operating Expenses
Total operating expenses:
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Domain]
External commercial costs
External Commercial Costs
External commercial costs.
Fair Value Measurements
Fair Value Disclosures [Text Block]
Proceeds from settlement of capped call.
Proceeds From Settlement Of Capped Call
Proceeds from settlement of capped call
Maximum [Member]
Maximum [Member]
Total liabilities and stockholders' equity
Liabilities and Equity
Royalties receivable
Royalties Receivable Current
Royalties receivable current.
Right-of-use assets
Operating Lease, Right-of-Use Asset
Right-of-use assets
Prepaid assets
Prepaid Expense, Current
Total prepaid assets
Earnings Per Share, Diluted
Net loss per common share, diluted
Net loss per common share, diluted
Total liabilities
Liabilities
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Total current assets
Assets, Current
Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities
Minimum Required Sales to Draw Additional Loan Under Credit Facility
Minimum required sales to draw additional loan under credit facility
Minimum required sales to draw additional loan under credit facility
Volume-weighted average price per share
Volume Weighted Average Price Per Share
Volume Weighted Average Price Per Share
Collaborative arrangement, up-front payment in next twelve months.
Collaborative Arrangement Up Front Payment In Next Twelve Months
Up-front payment on first anniversary of agreement on June 30, 2022
Forecast [Member]
Forecast [Member]
Unrecognized Tax Benefits, Beginning Balance
Unrecognized Tax Benefits, Ending Balance
Unrecognized Tax Benefits
Unrecognized tax benefits
Amended and Restated Patent License Agreement With Penn (Ophthalmic Field of Use) [Member]
Amended and Restated Patent License Agreement with Penn (Ophthalmic Field of Use.
Amended and Restated Patent License Agreement with Penn (Ophthalmic Field of Use) [Member]
Entity Filer Category
Entity Filer Category
Aggregate principal amount converted into shares
Debt Conversion, Converted Instrument, Shares Issued
Payment for Buyout of Development Liability Elimination
Payment for buyout of development liability elimination.
Payment for buyout of development liability elimination
Alec Machiels [Member]
Alec Machiels.
Accounts Receivable Remained Outstanding
Accounts receivable remained outstanding.
Outstanding amount of sold accounts receivable
Current Fiscal Year End Date
Current Fiscal Year End Date
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Share-based Payment Arrangement, Noncash Expense, Total
Share-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Related and Nonrelated Parties [Axis]
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Entity Registrant Name
Entity Registrant Name
Earnings Per Share [Text Block]
Net Loss per Common Share
Debt Instrument, Maturity Date
Credit facility maturity date
Entity Emerging Growth Company
Entity Emerging Growth Company
Product Revenues Accounts Receivable And Reserves For Product Sales [Abstract]
Product revenues, accounts receivable, and reserves for product sales.
Accretion of discount to development liability
Accretion Of Discount To Development Liability
Accretion of discount to development liability.
Down payments for inventory
Down Payments for Inventory Current
Down payments for inventory current.
ASU 2016-13 [Member]
Accounting Standards Update 2016-13 [Member]
Money Market Funds [Member]
Money Market Funds [Member]
Weighted Average Number of Shares Outstanding, Basic
Weighted-average number of common shares used in net loss per common share, basic
Weighted-average number of common shares used in net loss per common share, basic
Commercial costs
Commercial Costs Current
Commercial costs current.
Schedule of Line of Credit Facilities [Table Text Block]
Summary of Credit Facility
Transfer of Financial Assets Accounted for as Sales [Table Text Block]
Schedule of Factoring of Accounts Receivable and Associated Fees
Common stock, shares authorized
Common Stock, Shares Authorized
Mark DeLong [Member]
Mark DeLong.
Number of licensed products
Number Of Licensed Products
Number of licensed products.
Contract research and development expense
Contra Research And Development Expense
Contra research and development expense.
Proceeds from issuance of common stock, net of issuance costs
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock
Concentration Risk Type [Axis]
Level 1 [Member]
Fair Value, Inputs, Level 1 [Member]
Debt Disclosure [Abstract]
Vesting of restricted stock units, net of shares withheld for taxes
Restricted Stock, Value, Shares Issued Net of Tax Withholdings
call transactions remaining notional amount.
call transactions remaining notional amount
Call transactions remaining is a notional amount
Sobi Agreement and Another Licensing Transaction [Member]
Sobi Agreement And Another Licensing Transaction [Member]
Sobi agreement and another licensing transaction.
Milestone payment received for achievement of regulatory development milestone.
Milestone Payment Received for Achievement of Regulatory Development Milestone
Milestone payment received for achievement of regulatory development milestone
Collaborative arrangement upfront non-refundable amount payable.
Collaborative Arrangement Upfront Non Refundable Amount Payable
Up-front non-refundable payment
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
University Of Pennsylvania License Agreements [Member]
University Of Pennsylvania License Agreements.
University of Pennsylvania License Agreements [Member]
Accounting Policies [Abstract]
Income Tax Disclosure [Abstract]
Non-cancellable purchase commitments
Long-Term Purchase Commitment, Amount
Stockholders' equity:
Equity, Attributable to Parent [Abstract]
Supplemental Disclosure of Financing Activities
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract]
Government and Other Rebates [Member]
Allowance for Government and Other Rebates [Member]
Allowance for government and other rebates.
Statement [Table]
Statement [Table]
Inventory write-downs
Inventory Write-down
Reserve for excess and obsolete inventory
Debt Instruments [Abstract]
Other current assets
Increase (Decrease) in Other Current Assets
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Adjustments related to prior period sales
Product Revenue Allowances And Reserves, Adjustments Related To Prior Period Sales
Product revenue allowances and reserves, adjustments related to prior period sales.
Entity File Number
Entity File Number
Excercise Option Draw Amount Under Credit Facility
Excercise option draw amount under credit facility
Excercise option draw amount under credit facility
Segment Reporting Disclosure [Text Block]
Segment Information
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net decrease in cash, cash equivalents and restricted cash
Earnings Per Share [Abstract]
Contractual interest expense
Contractual Interest Expense
Contractual interest expense.
Inventory Disclosure [Abstract]
Prior to March 15, 2026 Convertible [Member]
Prior To March Fifteen Two Thousand And Twenty Six Convertible [Member]
Prior to March Fifteen Two Thousand and Twenty Six Convertible.
Statement of Financial Position [Abstract]
Net operating loss
Operating Income (Loss)
Entity Shell Company
Entity Shell Company
Collaborative arrangement, term of agreement.
Collaborative Arrangement Term Of Agreement
Collaboration agreement term
Schedule of Financial Instruments and the Related Fair Value Hierarchy of the Valuation Techniques Utilized
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Debt instrument effective interest rate
Debt Instrument, Interest Rate, Effective Percentage
Entity Tax Identification Number
Entity Tax Identification Number
Assets
Assets [Abstract]
Proceeds from Income Tax Refunds
Proceeds from income tax refunds net of income taxes paid
Entity Current Reporting Status
Entity Current Reporting Status
Segment Revenue Deductions [Abstract]
Segment revenue deductions.
Less:
Long-term Debt, Type
Long-Term Debt, Type [Axis]
Inventory
Inventory Disclosure [Text Block]
Document Fiscal Year Focus
Document Fiscal Year Focus
Bachem and NOF
Bachem and NOF Corporation [Member]
Bachem and NOF Corporation [Member]
Change in accounting principle accounting standards update adoption date
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued
Preferred stock, $0.0001 par value; 10,000 shares authorized, and zero shares issued and outstanding at March 31, 2025 and December 31, 2024
Development cost reimbursement
Development Cost Reimbursement
Development cost reimbursement.
Gross Product Revenues [Member]
Revenue, Product and Service Benchmark [Member]
City Area Code
City Area Code
Total current liabilities
Liabilities, Current
2019 and 2020 Convertible Notes [Member]
Two Thousand Nineteen And Two Thousand Twenty Convertible Notes [Member]
Two thousand nineteen and two thousand twenty convertible notes.
Line of Credit Facility, Lender [Domain]
Summary of Product Revenue Allowance and Reserve Categories
Product Revenue Reserves And Allowances [Table Text Block]
Product revenue reserves and allowances.
Proceeds from Debt, Net of Issuance Costs
Proceeds from net of isuance cost
Revised Additional Available Draw Amount Upon Satisfaction of Sales or Market Capitalization
Revised additional available draw amount upon Satisfaction of sales or market capitalization.
Revised Additional Available Draw Amount Upon Satisfaction of Sales or Market capitalization
Inventory
Total Inventories
Inventory, Net
Total Inventory
Finished goods
Inventory, Finished Goods, Gross
Inventory, Finished Goods, Gross, Total
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
U.S. federal statutory rate
Percentage of Prepayment Premium Under Credit Facility
Percentage of Prepayment Premium Under Credit Facility
Percentage of prepayment premium
Jeffrey R Eisele [Member]
Jeffrey R Eisele [Member]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Local Phone Number
Local Phone Number
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, outstanding
Preferred Stock, Shares Outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Additional Paid in Capital, Ending Balance
Additional Paid in Capital, Beginning Balance
Additional Paid in Capital, Total
Additional paid-in capital
Additional Paid in Capital
Vesting of restricted stock units, net of shares withheld for taxes. shares
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings
Commitments and Contingencies Disclosure [Abstract]
Fair Value By Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Accrued payroll liabilities.
Accrued Payroll Liabilities Current
Accrued payroll liabilities
Timothy E Sullivan [Member]
Timothy E Sullivan Member.
Operating Lease, Liability, Current
Current portion of lease liabilities
Proceeds From Sale Of Other Receivables Net Of Factoring Fees
Proceeds from sale of other receivables net of factoring fees.
Net cash proceeds
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Foreign currency gain (loss)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation
Convertible notes, interest rate
Debt instrument, stated percentage
Debt Instrument, Interest Rate, Stated Percentage
Retained Earnings [Member]
Accumulated Deficit [Member]
Retained Earnings [Member]
Payments to Acquire Property, Plant, and Equipment, Total
Purchase of property and equipment
Payments to Acquire Property, Plant, and Equipment
Convertible Senior Notes [Member]
Convertible Senior Notes [Member]
Convertible senior notes.
Document Transition Report
Document Transition Report
Summary of Interest Expense Recognized Related to Credit Facility [Table Text Block]
Summary of interest expense recognized related to credit facility.
Summary of Interest Expense Recognized Related to Credit Facility
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Minimum percentage of tax position likelihood of being realized upon examination by taxing authorities
Minimum Percentage Of Tax Position Likelihood Of Being Realized Upon Examination By Taxing Authorities
Minimum percentage of tax position likelihood of being realized upon examination by taxing authorities.
Returns [Member]
Sales Returns and Allowances [Member]
Less: debit discount and issuance costs, net
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Less: debt discount and issuance costs
Beam Therapeutics, Incorporation.
Beam Therapeutics Incorporation [Member]
Beam [Member]
Minimum [Member]
Minimum [Member]
Common Stock [Member]
Common Stock [Member]
Restricted Cash, Total
Restricted cash
Restricted Cash
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Payment of convertible debt offering expenses
Payment Of Convertible Debt Offering Expenses
Payment of convertible debt offering expenses.
Amortization Of Discounts For Credit Facility
Amortization of discounts for credit facility.
Amortization of discounts for credit facility
Other assets
Increase (Decrease) in Other Noncurrent Assets
Additional Paid-In Capital [Member]
Additional Paid-in Capital [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive gain:
Other Assets, Noncurrent, Total
Other assets
Other Assets, Noncurrent
Bachem Americas, Inc [Member]
Bachem Americas Inc [Member]
Bachem Americas Inc.
Segments [Domain]
Other prepaid expenses
Other Prepaid Expense, Current
Schedule of Inventory Current
Schedule of Inventory, Current [Table Text Block]
Total other current assets
Other current assets
Other Assets, Current
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Conversion ratio
Debt Instrument, Convertible, Conversion Ratio
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Scenario
Scenario [Domain]
Equity Component [Member]
Equity Component [Member]
Equity component.
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, $0.0001 par value; 200,000 shares authorized at March 31, 2025 and December 31, 2024; 125,661 shares issued and outstanding at March 31, 2025, and 124,495 shares issued and outstanding at December 31, 2024
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Caroline Baumal [Member]
Caroline Baumal [Member]
Product Revenues, Accounts Receivable, and Reserves for Product Sales
Product Revenues Accounts Receivable And Reserves For Product Sales [Text Block]
Product revenues, accounts receivable, and reserves for product sales.
Waived Payment
Waived payment.
Waived Payment
Cedric Francois [Member]
Cedric Francois.
Product Revenues Accounts Receivable And Reserves For Product Sales [Table]
Product Revenues Accounts Receivable And Reserves For Product Sales [Table]
Product revenues, accounts receivable, and reserves for product sales.
Asset-Based Financing Arrangement [Member]
Asset-based financing arrangement.
Measurement Frequency
Measurement Frequency [Axis]
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
Commitments and Contingencies
Commitments and contingencies (Note 11)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash paid for income taxes
Income Taxes Paid
Accrued Expenses [Member]
Accrued Liabilities Current [Member]
Accrued liabilities, current.
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average number of common shares used in net loss per common share, diluted
Weighted-average number of common shares used in net loss per common share, diluted
Convertible senior notes
Convertible Debt, Noncurrent
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of segment financial information
Revenue, Major Customer [Line Items]
Revenue, Major Customer [Line Items]
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivable, net
Increase (Decrease) in Inventories, Total
Inventory
Increase (Decrease) in Inventories
Minimum Required Financial Covenant if Capitalization Below Three Billion
Minimum required financial covenant if capitalization below three billion.
Minimum required financial covenant if capitalization below three billion
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Denominator:
Concentration Risk Benchmark [Domain]
Sublicense fee owed
Sublicense Fee Owed
Sublicense fee owed.
Entity Small Business
Entity Small Business
Segment Reporting Information [Line Items]
Debt Instrument, Basis Spread on Variable Rate
Variable interest rate percentage on base rate
Long-term Debt
Debt Disclosure [Text Block]
Convertible Notes [Member]
Convertible notes.
Convertible notes
Royalty revenue.
Royalty Revenue
Royalty revenue
Revenues
Revenues, Total
Revenue
Payment of factoring fees
Payment of factoring fees.
Less: factoring fees
Cost of sales
Operating Cost Of Sales
Operating cost of sales.
Accounting Standards Update and Change in Accounting Principle [Table]
Credit Facility [Axis]
Total future minimum payments
Aggregate milestones payments
Obligated to pay initial payment
Contractual Obligation
Redemption period, start date
Debt Instrument, Redemption Period, Start Date
Financing Activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Swedish Orphan Biovitrum A B Publ [Member]
Swedish Orphan Biovitrum AB (Publ) [Member]
Swedish Orphan Biovitrum AB (Publ).
Research collaboration agreement.
Research Collaboration Agreement [Member]
Research Collaboration Agreement [Member]
Asset Class
Asset Class [Axis]
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Measurement Frequency
Measurement Frequency [Domain]
Chargebacks, Discounts, and Fees [Member]
Allowance for Chargebacks Discounts and Fees [Member]
Allowance for chargebacks discounts and fees.
Semi-finished goods
Inventory, Work in Process, Gross
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Total other comprehensive income
Level 3 [Member]
Fair Value, Inputs, Level 3 [Member]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Change in accounting principle, accounting standards update, immaterial effect [true false]
Accounts receivable, net of discount and allowance
Accounts Receivable, Allowance for Credit Loss, Current
Prepaid research and development
Prepaid Research and Development Current
Prepaid research and development current.
Secured Overnight Financing Rate (SOFR) [Member]
SOFR [Member]
Increase (Decrease) in Accrued Liabilities, Total
Accrued expenses
Increase (Decrease) in Accrued Liabilities